Clinical trials sponsored by Shanghai Juncell Therapeutics

Phase breakdown

Conditions studied

Recruiting trials led by Shanghai Juncell Therapeutics

• A Phase II Study of GC101 in NSCLC
  NCT07560111 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Phase Ib Study of GC101 in NSCLC
  NCT06473961 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
  NCT05142475 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
  NCT05098197 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of GC101 TIL in Advanced Melanoma
  NCT06703398 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of GC101 TIL in Advanced Melanoma (10hospital)
  NCT05098184 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of GC203 TIL in PDCA (RJ)
  NCT06828328 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Shanghai Juncell Therapeutics recruiting for?

Shanghai Juncell Therapeutics is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.